814 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Legacy Capital Wealth Partners LLC

Legacy Capital Wealth Partners LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 814 shares of the medical equipment provider’s stock, valued at approximately $275,000.

A number of other hedge funds have also recently bought and sold shares of ISRG. Investment Partners LTD. grew its position in Intuitive Surgical by 5.1% in the 4th quarter. Investment Partners LTD. now owns 1,095 shares of the medical equipment provider’s stock worth $369,000 after purchasing an additional 53 shares in the last quarter. Addison Advisors LLC lifted its holdings in Intuitive Surgical by 52.5% during the fourth quarter. Addison Advisors LLC now owns 311 shares of the medical equipment provider’s stock worth $105,000 after acquiring an additional 107 shares during the period. Gilliland Jeter Wealth Management LLC purchased a new position in Intuitive Surgical in the fourth quarter worth $1,670,000. Golden State Equity Partners grew its stake in Intuitive Surgical by 19.7% in the 4th quarter. Golden State Equity Partners now owns 1,454 shares of the medical equipment provider’s stock valued at $491,000 after purchasing an additional 239 shares during the period. Finally, Cornerstone Capital Inc. increased its position in shares of Intuitive Surgical by 0.3% during the 4th quarter. Cornerstone Capital Inc. now owns 13,261 shares of the medical equipment provider’s stock valued at $4,474,000 after purchasing an additional 45 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 0.3 %

ISRG opened at $374.14 on Tuesday. The stock has a market capitalization of $132.71 billion, a P/E ratio of 67.53, a PEG ratio of 4.85 and a beta of 1.36. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $403.76. The stock has a 50-day moving average price of $386.10 and a 200-day moving average price of $347.50.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. Intuitive Surgical’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.00 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently weighed in on ISRG shares. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research report on Friday, April 19th. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a report on Friday, January 19th. Stifel Nicolaus increased their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Truist Financial boosted their target price on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Finally, Piper Sandler increased their price target on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research note on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $396.17.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 5,318 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the transaction, the executive vice president now directly owns 298 shares of the company’s stock, valued at $110,456.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Myriam Curet sold 5,318 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the completion of the sale, the executive vice president now owns 298 shares of the company’s stock, valued at $110,456.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now owns 1,842 shares in the company, valued at approximately $736,800. The disclosure for this sale can be found here. Insiders have sold a total of 225,093 shares of company stock worth $87,153,299 in the last 90 days. 0.80% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.